carbazilquinone has been researched along with Bladder Cancer in 18 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The rate of recurring bladder tumors decreased after instillation therapy." | 1.27 | [Experimental and clinical studies on intravesical instillation therapy for bladder cancer]. ( Imai, K; Kaburagi, Y; Miki, M; Yamanaka, H, 1983) |
| "The relapse rate of bladder cancer (transitional cell Ca) is said to be about 45%-80% even after tumor resection." | 1.27 | Evaluation of multidisciplinary treatment of bladder cancer, especially in chemoimmunotherapy (ADM and OK-432) as a consolidation therapy. ( Chin, H; Hiraoka, Y; Minowa, T; Nakagami, Y; Tozuka, K, 1983) |
| "We treated 25 bladder cancer patients with combined cytotoxic chemotherapy of adriamycin (10--20 mg/day administration on days 1, 2 and 3), carboquone (4 mg/day administration on day 1 of weeks 3, 4 and 5 and 5-Fu (200 mg/day for 5 weeks) or futraful suppositories (750 mg/day for 5 weeks) as one course." | 1.27 | [Combination chemotherapy with adriamycin, carboquone and 5-Fu for bladder cancer]. ( Hisazumi, H; Kojima, A; Mikawa, I; Misaki, T; Naitoh, K; Nakamura, T; Nango, C; Saitoh, Y; Tajiri, S; Uchibayashi, T, 1983) |
| "Responses of bladder cancer in ACI rats to combination therapy with an immunomodulator, PSK, and an alkylating agent, carboquone, are reported." | 1.27 | Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma. ( Mickey, DD, 1985) |
| "Urinary bladder tumors were induced in 9 of 11 rats (81." | 1.26 | [Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine]. ( Babaya, K; Hiramatsu, T; Hirao, Y; Horii, Y; Ijuin, M; Kaneko, Y; Kihoin, K; Kubota, K; Moriya, A; Ohara, S; Okajima, E; Okamoto, M; Okamura, K; Samma, S, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (94.44) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchibayashi, T | 3 |
| Moriyama, M | 1 |
| Kubota, Y | 1 |
| Miura, T | 1 |
| Shuin, T | 1 |
| Noguchi, S | 1 |
| Ohmori, H | 1 |
| Yoshida, O | 1 |
| Miyakawa, M | 1 |
| Watanabe, H | 1 |
| Mishina, T | 1 |
| Kobayashi, T | 2 |
| Nakagawa, K | 1 |
| Fukuyama, T | 1 |
| Ogura, K | 1 |
| Ueyama, H | 1 |
| Itoh, H | 1 |
| Yamanaka, H | 1 |
| Kaburagi, Y | 1 |
| Imai, K | 1 |
| Miki, M | 1 |
| Nakagami, Y | 2 |
| Minowa, T | 1 |
| Tozuka, K | 1 |
| Hiraoka, Y | 1 |
| Chin, H | 1 |
| Hisazumi, H | 2 |
| Saitoh, Y | 1 |
| Naitoh, K | 2 |
| Misaki, T | 2 |
| Nango, C | 1 |
| Tajiri, S | 1 |
| Nakamura, T | 1 |
| Kojima, A | 1 |
| Mikawa, I | 1 |
| Katoh, M | 1 |
| Nakajima, K | 1 |
| Kuroda, K | 1 |
| Matsumura, Y | 1 |
| Okajima, E | 1 |
| Hiramatsu, T | 1 |
| Okamoto, M | 1 |
| Kihoin, K | 1 |
| Ijuin, M | 1 |
| Hirao, Y | 1 |
| Ohara, S | 1 |
| Babaya, K | 1 |
| Kubota, K | 1 |
| Samma, S | 1 |
| Okamura, K | 1 |
| Kaneko, Y | 1 |
| Horii, Y | 1 |
| Moriya, A | 1 |
| Kato, T | 1 |
| Nemoto, R | 1 |
| Nishimoto, T | 1 |
| Kumagai, I | 1 |
| Miura, K | 1 |
| Saito, S | 1 |
| Takahashi, Y | 1 |
| Ooshima, H | 1 |
| Matuda, G | 1 |
| Hasuda, K | 1 |
| Kobayashi, H | 1 |
| Taniguchi, S | 1 |
| Baba, T | 1 |
| Tari, K | 1 |
| Satake, I | 1 |
| Kojima, S | 1 |
| Negishi, T | 1 |
| Yoshida, K | 1 |
| Nakame, Y | 1 |
| Kanaoya, F | 1 |
| Horiuchi, S | 1 |
| Saito, T | 1 |
| Owada, F | 1 |
| Maru, A | 1 |
| Nantani, M | 1 |
| Koyanagi, T | 1 |
| Ohashi, N | 1 |
| Yamada, T | 1 |
| Fujieda, J | 1 |
| Omuro, H | 1 |
| Nishida, T | 1 |
| Kusakai, Y | 1 |
| Amino, I | 1 |
| Kawano, S | 1 |
| Kubota, M | 1 |
| Tanaka, K | 1 |
| Ogawa, H | 1 |
| Mickey, DD | 1 |
| Kishimoto, T | 1 |
| Matsumoto, K | 1 |
18 other studies available for carbazilquinone and Bladder Cancer
| Article | Year |
|---|---|
[Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
Topics: Antineoplastic Agents; Bleomycin; Carbazilquinone; Carcinoma, Transitional Cell; Cell Division; Cell | 1983 |
[The effect of intravesical chemotherapy on superficial urinary bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Carcinoma, Papilla | 1983 |
[Intravesical chemotherapy for superficial bladder tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Cytarabine; Doxorubicin; | 1984 |
[Study of combination chemotherapy with cytosine arabinoside in the intravesical treatment of superficial bladder tumors].
Topics: Adult; Aged; Carbazilquinone; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Humans | 1983 |
[Experimental and clinical studies on intravesical instillation therapy for bladder cancer].
Topics: Adolescent; Adult; Aged; Carbazilquinone; Carcinoma, Transitional Cell; Cytodiagnosis; Doxorubicin; | 1983 |
Evaluation of multidisciplinary treatment of bladder cancer, especially in chemoimmunotherapy (ADM and OK-432) as a consolidation therapy.
Topics: Adjuvants, Immunologic; Aged; Alopecia; Biological Products; Carbazilquinone; Carcinoembryonic Antig | 1983 |
[Combination chemotherapy with adriamycin, carboquone and 5-Fu for bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Doxorubicin; Drug Evaluation; | 1983 |
Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer.
Topics: Adult; Aged; Antineoplastic Agents; Azirines; Carbazilquinone; Carcinoma, Transitional Cell; Cell Li | 1981 |
[Intravesical instillation of adriamycin and other antineoplastic agents].
Topics: Antineoplastic Agents; Carbazilquinone; Doxorubicin; Humans; Methods; Urinary Bladder; Urinary Bladd | 1982 |
[Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
Topics: Animals; Azirines; Butylhydroxybutylnitrosamine; Carbazilquinone; Male; Neoplasms, Experimental; Rat | 1982 |
Chemosensitivity of human bladder cancer cells in long-term culture and clinical responses to the selected anticancer drug.
Topics: Antineoplastic Agents; Azirines; Carbazilquinone; Carcinoma, Transitional Cell; Cell Line; Cell Surv | 1979 |
[Chemotherapy of bladder neoplasms--instillation of carboquone into the bladder].
Topics: Adult; Aged; Animals; Azirines; Carbazilquinone; Cytarabine; Drug Therapy, Combination; Female; Huma | 1977 |
Increased therapeutic efficacy of intra-arterial carboquone chemotherapy on a limb tumor in rats, by using an acidic vehicle adjusted with lactate.
Topics: Animals; Body Weight; Buffers; Carbazilquinone; Carcinoma, Transitional Cell; Extremities; Female; H | 1990 |
[Prophylactic intravesical chemotherapy in bladder tumors after surgery of upper tract urothelial carcinoma].
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilq | 1987 |
[Prophylactic chemotherapy of transitional cell carcinoma of the bladder: the efficacy of long-term bladder instillation].
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carci | 1986 |
[Experience of intra-arterial chemotherapy for advanced bladder cancer with antitumor agents].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cisplatin; Female; Flu | 1985 |
Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; Azirines; Body Weig | 1985 |
[Experimental study on immunochemotherapy (PSK, CQ) in rat bladder cancer (BC-47)].
Topics: Animals; Azirines; Body Weight; Carbazilquinone; Drug Synergism; Drug Therapy, Combination; Male; Ne | 1985 |